Vaginal Dryness and Menopause

Vaginal dryness after menopause is part of a broader condition called genitourinary syndrome of menopause — GSM — and it’s one of the most common reasons women contact our Cancun clinic. It affects a substantial proportion of postmenopausal women, and unlike hot flashes, which typically ease over time, GSM is progressive — without treatment it generally worsens rather than resolves.

We start there because the most common thing women tell our Cancun medical team is that they assumed this was simply aging and nothing could be done. That belief is inaccurate, widely held, and it keeps people uncomfortable for years unnecessarily.

We’re going to be equally direct about something else. The established treatments for GSM are effective and well studied, and for most women they should be tried first. Regenerative approaches for this condition are early-stage — thinner evidence than for several other conditions treated at our Cancun clinic. We would rather tell you that here than after you’ve booked a flight to Cancun on the strength of a claim that doesn’t hold up.

Have questions about your symptoms? Our Cancun medical team can talk through where you are and what you’ve already tried. Request a consultation →

What Actually Changes, and Why

Estrogen maintains the vaginal and vulvar tissues. As levels decline through perimenopause and after menopause, several changes occur together — which is why GSM presents as a cluster rather than a single symptom.

The tissue thins. The vaginal epithelium loses cell layers. Tissue that was thick and resilient becomes fragile, more easily irritated, and prone to microtears and post-coital bleeding.

Lubrication decreases. Fewer secretions at baseline, and a slower, less complete response during arousal. Many women notice the arousal-response change before the baseline change.

Blood flow reduces. Less vascularization means less tissue resilience and slower healing from minor irritation.

Elasticity declines. Collagen and elastin content shift. The tissue becomes less able to stretch comfortably, which is a frequent contributor to pain during intercourse.

pH rises. The protective acidic environment maintained by lactobacilli shifts toward neutral. This is why recurrent urinary tract infections and bacterial imbalance frequently accompany GSM — it is not a coincidence and it is not separate.

Urinary symptoms appear. Urgency, frequency, discomfort with urination, and increased UTI susceptibility. The “genitourinary” in the name is doing deliberate work — the urethra and bladder trigone are estrogen-responsive tissues too.

Women who come to our Cancun clinic frequently describe only the dryness, then recognize three or four of the others once they’re named. They are one condition with one underlying cause.

Why It Goes Undiagnosed for Years

Surveys consistently find that most women with GSM symptoms never raise them with a clinician, and that clinicians frequently don’t ask. Both halves of that failure are well documented.

The reasons are familiar — an assumption that it’s a normal part of aging, discomfort discussing sexual symptoms, short appointment times, and, for many women, never having been told the condition has a name.

The result is a treatable, progressive condition running unaddressed for years, sometimes decades.

If you take one thing from this page: raise it with your physician.

That conversation is more valuable than any treatment decision, including whether to consider anything at our Cancun facility. A woman who reads this page and books a gynecology appointment rather than a flight to Cancun has, in our view, used it correctly.

Established Treatments, and Why They Come First

We are a clinic in Cancun that offers regenerative therapy. We are still going to tell you to try these first, because the evidence says so.

Vaginal moisturizers and lubricants. Non-hormonal and available without prescription. Moisturizers are used regularly — several times weekly — and hydrate tissue over time. Lubricants are used at the time of intercourse and address friction rather than tissue health. They serve different purposes and are often confused. Effective for milder symptoms, and worth doing properly before concluding they don’t work.

Local vaginal estrogen. This is the most established treatment for GSM and the one most women benefit from. Delivered as creams, tablets, inserts or a ring, it acts on the tissue directly with minimal systemic absorption. Critically, it reverses underlying tissue changes rather than masking symptoms — epithelial thickness, blood flow, elasticity and pH can all improve. Guidance from The Menopause Society supports its use for GSM, including — with appropriate individualized discussion — for many women who cannot take systemic hormone therapy. Women with a history of breast cancer represent a specific situation requiring coordination with an oncology team, and that conversation is worth having rather than assuming the answer is no.

Prescription and Physical Therapy Options

Systemic hormone therapy. Appropriate where GSM occurs alongside other menopausal symptoms such as hot flashes and sleep disruption. It addresses GSM less completely than local estrogen in some women, and the two are sometimes used together.

Non-hormonal prescription options. Selective estrogen receptor modulators and intravaginal DHEA preparations offer alternatives where estrogen is unsuitable or unwanted.

Pelvic floor physical therapy. Frequently overlooked and genuinely valuable, particularly where pain, muscle guarding or urinary symptoms are present. Pain causes protective muscle tension, which causes more pain. Breaking that loop sometimes accomplishes what topical treatment alone cannot.

Our Cancun physicians ask every woman whether she has tried local vaginal estrogen. Recommending an investigational therapy to someone who hasn’t tried the best-supported treatment would put our services ahead of your interests.

A note on why moisturizers alone sometimes disappoint. They hydrate tissue temporarily, but they don’t reverse the underlying thinning and reduced blood flow driving the problem. Women who try a moisturizer for a few weeks, see modest improvement, and stop are often experiencing exactly what the evidence predicts — symptom relief without the tissue-level change that local estrogen can provide.

Where Regenerative Therapy Actually Stands

Here is the honest position, and it is less favourable than for the men’s conditions treated at our Cancun clinic.

The published evidence for regenerative approaches to GSM and female sexual dysfunction is earlier-stage than the male-side evidence. It consists largely of narrative reviews, animal models, and registered trial protocols rather than completed human trials with meaningful follow-up and control groups.

Related work in ovarian rejuvenation and premature ovarian insufficiency using platelet-rich plasma has produced pilot-level results from small before-and-after studies — not randomized controlled confirmation. Before-and-after designs without controls are particularly vulnerable to regression to the mean and expectation effects.

On MUSE cells specifically: Dezawa MuseCells® have been studied in registered human clinical trials for stroke, acute myocardial infarction, spinal cord injury, ALS, dystrophic epidermolysis bullosa, neonatal hypoxic-ischemic encephalopathy and ARDS. There is no published human clinical trial for GSM, vaginal atrophy, or any female sexual indication.

That is a real limitation and we will not dress it up. Women’s sexual health has been chronically under-researched relative to men’s, and the regenerative evidence base reflects that broader neglect rather than any special deficiency of the approach. But an explanation for thin evidence is not a substitute for evidence.

If a clinic in Cancun or anywhere else tells you regenerative therapy is proven for vaginal dryness, they are not telling you the truth, and our Cancun physicians will say the same thing in person.

What That Means Practically

It means regenerative therapy is reasonable to consider — after established options have been tried, in consultation with a physician, with clear-eyed expectations about an investigational intervention in a condition where the evidence is early.

It does not mean it should be your first step. It does not mean anyone can promise you a result. And it means the women for whom this makes most sense are typically those who have worked through established treatment with a knowledgeable clinician and found it insufficient — not those who have just learned the condition has a name.

Your Options Compared

Moisturizers and lubricants address symptom relief and are established — a reasonable first step. Local vaginal estrogen is established and best-supported, reversing underlying tissue changes with minimal systemic absorption. Systemic hormone therapy is established, sometimes combined with local treatment. Non-hormonal prescription options are established, useful where estrogen is unsuitable. Pelvic floor physical therapy is established and underused. Laser and radiofrequency devices are contested, with regulatory concerns raised about marketing claims. PRP-based injections are experimental, with preparation varying widely between clinics. Stem cell therapy is investigational and early-stage for this indication specifically, with no human trial for GSM.

On branded protocols. You may encounter the O-Shot®, a registered trademark of the Cellular Medicine Association describing a specific PRP injection protocol. RejuvStem is not affiliated with, licensed by, or a provider of the O-Shot®. We mention it because comparing clinics is genuinely difficult when different names are used for overlapping things.

What Our Consultation Screens For

Every patient goes through a medical consultation before any treatment plan is set. Here is what our Cancun physicians are checking for.

Whether you’ve tried local vaginal estrogen. This is the single most common gap we see, and it comes before anything else in the conversation.

Whether your symptoms fit the GSM pattern or point somewhere else. Persistent bleeding, unusual discharge or pain that doesn’t match a typical GSM presentation warrants its own evaluation, sometimes urgently, before any regenerative discussion.

Whether an oncology history changes what’s appropriate. If you’ve had breast cancer or another hormone-sensitive condition, that history shapes which established options are on the table and how we approach anything else.

Whether pelvic floor dysfunction is contributing. Pain and muscle guarding sometimes need their own treatment before tissue-level therapy of any kind will help.

Whether your expectations match what an investigational therapy can realistically offer for this specific indication. Given how early the evidence is here, that conversation matters more for GSM than for several other conditions we treat.

Why Patients Consider Cancun

Access. Cancun International Airport offers nonstop service from most major US and Canadian cities, with our clinic roughly fifteen minutes away.

A defined regulatory framework. Stem cell therapy is legal in Mexico under COFEPRIS, the federal health regulator. Clinics in Cancun handling cells and tissues require specific authorizations, and physicians must hold a valid cédula profesional, verifiable publicly at cedulaprofesional.sep.gob.mx.

Allogeneic cells. RejuvStem is an authorized partner of MuseCell Innovations® in Mexico, using allogeneic MUSE cells — donor-derived and screened rather than harvested from your own body, meaning no tissue-harvesting procedure. We never describe our cells as autologous.

Time for a proper evaluation. Women repeatedly tell our Cancun team that the consultation was the first time a clinician actually walked through the full GSM symptom cluster with them rather than addressing dryness in isolation. That’s a benefit of the consultation itself, and it’s worth knowing a menopause-focused clinician closer to home may offer the same thoroughness.

Logistics and Trade-Offs

Practical logistics. Cancun’s tourism infrastructure means accommodation across a wide range, a large English-speaking service sector, and a clinical team that works in both English and Spanish. International patients make up a substantial share of who we see at our Cancun facility, and many women tell us that matters — a team accustomed to menopausal care in patients from outside Mexico tends to anticipate questions a less experienced clinic might miss. We don’t publish treatment pricing because a genuine figure depends on consultation, though we discuss Cancun travel and accommodation costs openly.

The honest trade-offs, two of them. First, care in Cancun means follow-up at a distance, which requires a specific plan rather than an assumption. Second, and specific to this condition, the evidence supporting regenerative therapy for GSM is thinner than for several other conditions we treat. Both deserve genuine weight in your decision, and we’d rather state them here than have you discover them later.

Want an honest assessment? Our Cancun team will ask what you’ve already tried, and will tell you if established treatment makes more sense for you. Request a consultation →

What a Cancun Consultation Involves

Not a protocol — a general sequence. Specifics belong in consultation with a physician who has assessed you.

Before you travel. A remote consultation comes first. Our Cancun physicians ask what you’ve tried — moisturizers, lubricants, local vaginal estrogen, systemic hormone therapy, pelvic floor therapy — and how each performed. A substantial number of women are advised at this stage to pursue established treatment with a gynecologist at home rather than travel to Cancun at all. We’d rather give that advice than take a booking that doesn’t serve you.

What’s worth bringing. A current medication list, menopausal history including surgical menopause, any oncology history, and a record of treatments already tried with their results. Women who arrive in Cancun without this find the consultation less precise than it should be.

The examination. Assessment of GSM at our Cancun clinic involves examination, which is discussed and consented to in advance. Our Cancun team includes clinicians experienced in menopausal care, and you may request a female clinician be present. Our Cancun clinic operates within a fully certified private hospital, so any concern during your visit can be addressed immediately.

Afterward. Follow-up happens remotely. For a progressive condition like GSM, ongoing care with a clinician at home matters, and we’d encourage you to maintain it rather than substitute a single visit to Cancun for continuity.

What we will not publish. Session counts, timing, dosages or frequencies — those belong in consultation with a physician who has assessed you.

Questions Worth Asking Any Clinic

• •Have you asked whether I’ve tried local vaginal estrogen?
• •What published human evidence exists for this indication specifically?
• •Is what you’re administering allogeneic or autologous?
• •What is your regulatory authorization number?
• •What is the treating physician’s cédula profesional?
• •What degree of improvement is realistic for this specific condition?
• •What happens if it doesn’t work?

Frequently Asked Questions

Is vaginal dryness after menopause normal?

It’s common, but common isn’t the same as untreatable or inevitable. GSM is a recognized medical condition that typically worsens without treatment. It’s worth raising with your physician.

Does stem cell therapy cure vaginal dryness?

No. It’s investigational for this indication and the published evidence is early-stage — largely reviews, animal models and trial protocols rather than completed human trials. Nobody can honestly promise you a result.

Should I try vaginal estrogen first?

For most women, yes. It’s the best-supported treatment for GSM and it addresses underlying tissue changes. Our Cancun physicians will ask whether you’ve tried it.

Is it FDA approved?

No. The FDA has not approved stem cell therapy for GSM or any female sexual indication. Treatment at our Cancun clinic operates under Mexican COFEPRIS regulation.

Can I use vaginal estrogen if I’ve had breast cancer?

This requires coordination with your oncology team. It isn’t automatically ruled out — guidance supports individualized decision-making — but it’s genuinely a conversation to have with the clinicians managing your cancer care.

Why do I keep getting urinary tract infections?

Rising vaginal pH after menopause shifts the protective bacterial environment, increasing susceptibility. Recurrent UTIs are a recognized part of GSM rather than a separate problem, and treating the underlying condition often helps.

Do you offer the O-Shot®?

No. It’s a registered trademark of the Cellular Medicine Association and RejuvStem is not affiliated with or licensed by them.

How much does treatment cost?

We don’t publish figures — pricing depends on your consultation. We discuss Cancun travel and accommodation costs openly and provide a personalized quote after assessment.

Do I need a consultation before travelling to Cancun?

Yes. Every patient goes through a medical consultation before any plan is set, and we require it before you book travel.

Will this help my low libido too?

Sometimes indirectly — pain and discomfort reliably suppress desire, so addressing them can help. But desire has multiple causes and deserves separate evaluation. Our low libido page covers that in detail.

Is RejuvStem’s Cancun clinic accredited?

Our facility operates within a fully certified private hospital under COFEPRIS regulation, with authorization numbers published on this site and physician licenses independently verifiable.

What if my symptoms don’t match typical GSM?

Persistent bleeding, unusual discharge or pain that doesn’t fit the typical pattern deserves its own evaluation, sometimes promptly, before any discussion of regenerative therapy. Our Cancun physicians will tell you if that’s what your history suggests.

Can I bring someone with me to Cancun?

Many women do, whether a partner or a friend. Some prefer to attend alone, and both are reasonable.

Are MUSE cells proven for women’s sexual health?

No. MUSE cells have human trial data in stroke, myocardial infarction, spinal cord injury and other conditions — not female sexual indications.

Ready to talk it through? Every patient goes through a medical consultation with our Cancun team, who will review your symptoms and what you have already tried before discussing whether regenerative therapy is a reasonable consideration — or whether something better established fits you. Request a consultation →

RejuvStem is an authorized partner of MuseCell Innovations® in Mexico, operating in Cancun. Stem cell therapy for female sexual indications is investigational and is not approved by the US FDA. The evidence base for regenerative approaches to GSM is early-stage, and no published human clinical trial exists for MUSE cells in any female sexual indication. Individual results vary and no outcome is guaranteed. This page is general information, not medical advice. O-Shot® is a registered trademark of the Cellular Medicine Association; RejuvStem is not affiliated with, licensed by, or a provider of it.